Anavex Life Sciences Corp (AVXL)

[skitahoe]

From several of the posts I've now read from a variety of posters it's clear that management is accused of being far to secretive. Sadly, it's a criticism I've found in practically every biotech I've followed. Certainly Missling found that in working at IMGN. Frankly I hate to say it, but I believe that it's encouraged by the regulators who abhor hype. There are companies who've been much more open, CVM and DNDN come to mind, but they've not been successful, at least not to date, though DNDN did get Provenge approved. CVM has tried their technology against many targets, each time it fails they announce a new target they're confident of curing. I see them as a cure in search of its disease.

I believe the good news will come, but only when the company is ready to announce it. Hopefully they're preparing for a well orchestrated PR campaign.

Gary